• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022

    7/7/22 10:04:41 AM ET
    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Major Banks
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ABTX alert in real time by email

    Upgrades

    For Pacific Premier Bancorp Inc (NASDAQ:PPBI), Raymond James upgraded the previous rating of Outperform to Strong Buy. In the first quarter, Pacific Premier Bancorp showed an EPS of $0.70, compared to $0.72 from the year-ago quarter. At the moment, the stock has a 52-week-high of $45.24 and a 52-week-low of $27.92. Pacific Premier Bancorp closed at $30.08 at the end of the last trading period.

    For Heritage Commerce Corp (NASDAQ:HTBK), Raymond James upgraded the previous rating of Outperform to Strong Buy. For the first quarter, Heritage Commerce had an EPS of $0.21, compared to year-ago quarter EPS of $0.19. The current stock performance of Heritage Commerce shows a 52-week-high of $12.94 and a 52-week-low of $10.43. Moreover, at the end of the last trading period, the closing price was at $10.82.

    Citigroup upgraded the previous rating for Lamar Advertising Co (NASDAQ:LAMR) from Neutral to Buy. In the first quarter, Lamar Advertising showed an EPS of $0.91, compared to $0.38 from the year-ago quarter. The current stock performance of Lamar Advertising shows a 52-week-high of $124.32 and a 52-week-low of $83.96. Moreover, at the end of the last trading period, the closing price was at $88.41.

    According to Raymond James, the prior rating for Allegiance Bancshares Inc (NASDAQ:ABTX) was changed from Market Perform to Outperform. For the first quarter, Allegiance Bancshares had an EPS of $0.91, compared to year-ago quarter EPS of $0.89. At the moment, the stock has a 52-week-high of $46.00 and a 52-week-low of $34.30. Allegiance Bancshares closed at $39.02 at the end of the last trading period.

    Raymond James upgraded the previous rating for Texas Capital Bancshares Inc (NASDAQ:TCBI) from Outperform to Strong Buy. Texas Capital Bancshares earned $0.69 in the first quarter, compared to $1.33 in the year-ago quarter. The stock has a 52-week-high of $71.60 and a 52-week-low of $48.79. At the end of the last trading period, Texas Capital Bancshares closed at $53.09.

    For Regions Financial Corp (NYSE:RF), Raymond James upgraded the previous rating of Market Perform to Outperform. Regions Financial earned $0.55 in the first quarter, compared to $0.63 in the year-ago quarter. At the moment, the stock has a 52-week-high of $25.57 and a 52-week-low of $18.02. Regions Financial closed at $18.56 at the end of the last trading period.

    According to Raymond James, the prior rating for First Mid Bancshares Inc (NASDAQ:FMBH) was changed from Market Perform to Outperform. For the first quarter, First Mid Bancshares had an EPS of $0.96, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $45.84 and a 52-week-low of $35.05. At the end of the last trading period, First Mid Bancshares closed at $36.22.

    According to Raymond James, the prior rating for First Merchants Corp (NASDAQ:FRME) was changed from Outperform to Strong Buy. For the first quarter, First Merchants had an EPS of $0.88, compared to year-ago quarter EPS of $0.91. At the moment, the stock has a 52-week-high of $46.12 and a 52-week-low of $35.07. First Merchants closed at $35.87 at the end of the last trading period.

    Raymond James upgraded the previous rating for Carter Bankshares Inc (NASDAQ:CARE) from Market Perform to Outperform. Carter Bankshares earned $0.36 in the first quarter, compared to $0.36 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.99 and a 52-week-low of $10.02. Carter Bankshares closed at $13.15 at the end of the last trading period.

    For Pinnacle Financial Partners Inc (NASDAQ:PNFP), Raymond James upgraded the previous rating of Market Perform to Outperform. In the first quarter, Pinnacle Finl Partners showed an EPS of $1.65, compared to $1.61 from the year-ago quarter. At the moment, the stock has a 52-week-high of $111.31 and a 52-week-low of $67.90. Pinnacle Finl Partners closed at $72.46 at the end of the last trading period.

    For PPL Corp (NYSE:PPL), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the first quarter, PPL had an EPS of $0.41, compared to year-ago quarter EPS of $0.28. The current stock performance of PPL shows a 52-week-high of $30.71 and a 52-week-low of $24.98. Moreover, at the end of the last trading period, the closing price was at $27.05.

    According to Truist Securities, the prior rating for Adverum Biotechnologies Inc (NASDAQ:ADVM) was changed from Hold to Buy. For the first quarter, Adverum Biotechnologies had an EPS of $0.38, compared to year-ago quarter EPS of $0.29. At the moment, the stock has a 52-week-high of $3.66 and a 52-week-low of $0.80. Adverum Biotechnologies closed at $1.23 at the end of the last trading period.

    For EPR Properties (NYSE:EPR), Janney Montgomery Scott upgraded the previous rating of Neutral to Buy. EPR Props earned $1.10 in the first quarter, compared to $0.48 in the year-ago quarter. The stock has a 52-week-high of $56.38 and a 52-week-low of $41.14. At the end of the last trading period, EPR Props closed at $47.14.

    According to BTIG, the prior rating for 1Life Healthcare Inc (NASDAQ:ONEM) was changed from Neutral to Buy. For the first quarter, 1Life Healthcare had an EPS of $0.47, compared to year-ago quarter EPS of $0.29. The current stock performance of 1Life Healthcare shows a 52-week-high of $33.72 and a 52-week-low of $5.94. Moreover, at the end of the last trading period, the closing price was at $10.28.

    According to Wells Fargo, the prior rating for Bank of N.T Butterfield & Son Ltd (NYSE:NTB) was changed from Equal-Weight to Overweight. For the first quarter, Bank of N.T Butterfield had an EPS of $0.90, compared to year-ago quarter EPS of $0.83. The stock has a 52-week-high of $41.69 and a 52-week-low of $28.67. At the end of the last trading period, Bank of N.T Butterfield closed at $30.94.

    Daiwa Capital upgraded the previous rating for Merck & Co Inc (NYSE:MRK) from Hold to Outperform. For the first quarter, Merck & Co had an EPS of $2.14, compared to year-ago quarter EPS of $1.40. At the moment, the stock has a 52-week-high of $95.72 and a 52-week-low of $70.89. Merck & Co closed at $93.13 at the end of the last trading period.

    According to RBC Capital, the prior rating for Cerence Inc (NASDAQ:CRNC) was changed from Underperform to Sector Perform. For the second quarter, Cerence had an EPS of $0.33, compared to year-ago quarter EPS of $0.69. The current stock performance of Cerence shows a 52-week-high of $126.40 and a 52-week-low of $24.35. Moreover, at the end of the last trading period, the closing price was at $25.74.

    Jefferies upgraded the previous rating for Tenaris SA (NYSE:TS) from Hold to Buy. Tenaris earned $0.85 in the first quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.76 and a 52-week-low of $18.80. Tenaris closed at $22.89 at the end of the last trading period.

    See all analyst ratings upgrades.

    Downgrades

    According to Raymond James, the prior rating for Preferred Bank (NASDAQ:PFBC) was changed from Outperform to Market Perform. In the first quarter, Preferred Bank showed an EPS of $1.74, compared to $1.42 from the year-ago quarter. At the moment, the stock has a 52-week-high of $81.97 and a 52-week-low of $57.27. Preferred Bank closed at $69.27 at the end of the last trading period.

    According to Scotiabank, the prior rating for Cornerstone Building Brands Inc (NYSE:CNR) was changed from Sector Outperform to Sector Perform. Cornerstone Building earned $0.66 in the first quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.61 and a 52-week-low of $13.51. Cornerstone Building closed at $24.54 at the end of the last trading period.

    Raymond James downgraded the previous rating for FS Bancorp Inc (NASDAQ:FSBW) from Outperform to Market Perform. FS Bancorp earned $0.81 in the first quarter, compared to $1.35 in the year-ago quarter. The stock has a 52-week-high of $71.68 and a 52-week-low of $28.09. At the end of the last trading period, FS Bancorp closed at $28.76.

    For Canadian Pacific Railway Ltd (NYSE:CP), Scotiabank downgraded the previous rating of Sector Outperform to Sector Perform. In the first quarter, Canadian Pacific Railway showed an EPS of $0.53, compared to $0.71 from the year-ago quarter. The current stock performance of Canadian Pacific Railway shows a 52-week-high of $84.22 and a 52-week-low of $64.37. Moreover, at the end of the last trading period, the closing price was at $71.65.

    According to Raymond James, the prior rating for Sierra Bancorp (NASDAQ:BSRR) was changed from Outperform to Market Perform. For the first quarter, Sierra Bancorp had an EPS of $0.49, compared to year-ago quarter EPS of $0.72. At the moment, the stock has a 52-week-high of $28.92 and a 52-week-low of $20.77. Sierra Bancorp closed at $21.42 at the end of the last trading period.

    Oppenheimer downgraded the previous rating for DiaMedica Therapeutics Inc (NASDAQ:DMAC) from Outperform to Perform. For the first quarter, DiaMedica Therapeutics had an EPS of $0.13, compared to year-ago quarter EPS of $0.19. The current stock performance of DiaMedica Therapeutics shows a 52-week-high of $4.82 and a 52-week-low of $1.62. Moreover, at the end of the last trading period, the closing price was at $2.02.

    Jefferies downgraded the previous rating for CytomX Therapeutics Inc (NASDAQ:CTMX) from Buy to Hold. CytomX Therapeutics earned $0.37 in the first quarter, compared to $0.26 in the year-ago quarter. The current stock performance of CytomX Therapeutics shows a 52-week-high of $7.53 and a 52-week-low of $1.50. Moreover, at the end of the last trading period, the closing price was at $1.97.

    For Kohl's Corp (NYSE:KSS), Gordon Haskett downgraded the previous rating of Accumulate to Hold. For the first quarter, Kohl's had an EPS of $0.11, compared to year-ago quarter EPS of $1.05. The current stock performance of Kohl's shows a 52-week-high of $64.38 and a 52-week-low of $27.31. Moreover, at the end of the last trading period, the closing price was at $27.37.

    According to Argus Research, the prior rating for United Airlines Holdings Inc (NASDAQ:UAL) was changed from Buy to Hold. In the first quarter, United Airlines Holdings showed an EPS of $4.24, compared to $4.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $54.52 and a 52-week-low of $30.54. United Airlines Holdings closed at $36.66 at the end of the last trading period.

    According to Raymond James, the prior rating for Bank OZK (NASDAQ:OZK) was changed from Outperform to Market Perform. In the first quarter, Bank OZK showed an EPS of $1.02, compared to $1.11 from the year-ago quarter. The stock has a 52-week-high of $51.39 and a 52-week-low of $34.79. At the end of the last trading period, Bank OZK closed at $37.82.

    For PacWest Bancorp (NASDAQ:PACW), Raymond James downgraded the previous rating of Strong Buy to Market Perform. PacWest Banc earned $1.01 in the first quarter, compared to $1.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.81 and a 52-week-low of $25.60. PacWest Banc closed at $26.96 at the end of the last trading period.

    For Horizon Bancorp (IN) (NASDAQ:HBNC), Raymond James downgraded the previous rating of Strong Buy to Outperform. For the first quarter, Horizon Bancorp had an EPS of $0.54, compared to year-ago quarter EPS of $0.44. At the moment, the stock has a 52-week-high of $23.80 and a 52-week-low of $15.66. Horizon Bancorp closed at $17.82 at the end of the last trading period.

    Raymond James downgraded the previous rating for Dime Community Bancshares Inc (NASDAQ:DCOM) from Strong Buy to Outperform. Dime Community Bancshares earned $0.82 in the first quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of $38.35 and a 52-week-low of $28.36. At the end of the last trading period, Dime Community Bancshares closed at $30.30.

    Raymond James downgraded the previous rating for First Financial Corp (NASDAQ:THFF) from Outperform to Market Perform. First Financial earned $1.67 in the first quarter, compared to $0.95 in the year-ago quarter. The stock has a 52-week-high of $47.10 and a 52-week-low of $37.70. At the end of the last trading period, First Financial closed at $45.00.

    For FVCBankcorp Inc (NASDAQ:FVCB), Raymond James downgraded the previous rating of Strong Buy to Outperform. FVCBankcorp earned $0.46 in the first quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $21.90 and a 52-week-low of $16.43. At the end of the last trading period, FVCBankcorp closed at $18.97.

    For Lakeland Bancorp Inc (NASDAQ:LBAI), Raymond James downgraded the previous rating of Strong Buy to Outperform. For the first quarter, Lakeland Bancorp had an EPS of $0.25, compared to year-ago quarter EPS of $0.45. The stock has a 52-week-high of $20.69 and a 52-week-low of $14.40. At the end of the last trading period, Lakeland Bancorp closed at $14.82.

    For Southern Copper Corp (NYSE:SCCO), Wolfe Research downgraded the previous rating of Peer Perform to Underperform. For the first quarter, Southern Copper had an EPS of $1.02, compared to year-ago quarter EPS of $0.99. At the moment, the stock has a 52-week-high of $79.31 and a 52-week-low of $46.50. Southern Copper closed at $48.76 at the end of the last trading period.

    According to Raymond James, the prior rating for Meta Financial Group Inc (NASDAQ:CASH) was changed from Strong Buy to Outperform. Meta Financial Group earned $1.73 in the second quarter, compared to $1.84 in the year-ago quarter. The current stock performance of Meta Financial Group shows a 52-week-high of $65.95 and a 52-week-low of $36.02. Moreover, at the end of the last trading period, the closing price was at $40.75.

    For CytomX Therapeutics Inc (NASDAQ:CTMX), Wedbush downgraded the previous rating of Outperform to Neutral. In the first quarter, CytomX Therapeutics showed an EPS of $0.37, compared to $0.26 from the year-ago quarter. The current stock performance of CytomX Therapeutics shows a 52-week-high of $7.53 and a 52-week-low of $1.50. Moreover, at the end of the last trading period, the closing price was at $1.97.

    Raymond James downgraded the previous rating for SmartFinancial Inc (NASDAQ:SMBK) from Strong Buy to Outperform. For the first quarter, SmartFinancial had an EPS of $0.51, compared to year-ago quarter EPS of $0.65. At the moment, the stock has a 52-week-high of $28.63 and a 52-week-low of $22.63. SmartFinancial closed at $23.80 at the end of the last trading period.

    According to TD Securities, the prior rating for Resolute Forest Products Inc (NYSE:RFP) was changed from Buy to Hold. Resolute Forest Prods earned $2.26 in the first quarter, compared to $1.45 in the year-ago quarter. The current stock performance of Resolute Forest Prods shows a 52-week-high of $20.71 and a 52-week-low of $9.84. Moreover, at the end of the last trading period, the closing price was at $20.36.

    Raymond James downgraded the previous rating for First Commonwealth Financial Corp (NYSE:FCF) from Outperform to Market Perform. For the first quarter, First Commonwealth had an EPS of $0.29, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $17.63 and a 52-week-low of $12.36. At the end of the last trading period, First Commonwealth closed at $13.58.

    According to Raymond James, the prior rating for CapStar Financial Holdings Inc (NASDAQ:CSTR) was changed from Outperform to Market Perform. In the first quarter, CapStar Finl Hldgs showed an EPS of $0.48, compared to $0.50 from the year-ago quarter. The current stock performance of CapStar Finl Hldgs shows a 52-week-high of $22.74 and a 52-week-low of $18.92. Moreover, at the end of the last trading period, the closing price was at $19.57.

    For Cambridge Bancorp (NASDAQ:CATC), Raymond James downgraded the previous rating of Outperform to Market Perform. Cambridge earned $1.89 in the first quarter, compared to $1.92 in the year-ago quarter. At the moment, the stock has a 52-week-high of $97.57 and a 52-week-low of $77.62. Cambridge closed at $82.45 at the end of the last trading period.

    Raymond James downgraded the previous rating for Live Oak Bancshares Inc (NASDAQ:LOB) from Outperform to Market Perform. For the first quarter, Live Oak Bancshares had an EPS of $0.76, compared to year-ago quarter EPS of $0.88. At the moment, the stock has a 52-week-high of $99.89 and a 52-week-low of $32.05. Live Oak Bancshares closed at $33.40 at the end of the last trading period.

    According to Raymond James, the prior rating for Veritex Holdings Inc (NASDAQ:VBTX) was changed from Strong Buy to Outperform. In the first quarter, Veritex Holdings showed an EPS of $0.66, compared to $0.64 from the year-ago quarter. The current stock performance of Veritex Holdings shows a 52-week-high of $45.36 and a 52-week-low of $27.28. Moreover, at the end of the last trading period, the closing price was at $29.82.

    Raymond James downgraded the previous rating for PNC Financial Services Group Inc (NYSE:PNC) from Outperform to Market Perform. PNC Financial Services Gr earned $3.29 in the first quarter, compared to $4.10 in the year-ago quarter. The stock has a 52-week-high of $228.14 and a 52-week-low of $149.51. At the end of the last trading period, PNC Financial Services Gr closed at $160.03.

    According to Raymond James, the prior rating for Hilltop Holdings Inc (NYSE:HTH) was changed from Market Perform to Underperform. In the first quarter, Hilltop Holdings showed an EPS of $0.28, compared to $1.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $38.47 and a 52-week-low of $25.07. Hilltop Holdings closed at $27.42 at the end of the last trading period.

    For Guaranty Bancshares Inc (NASDAQ:GNTY), Raymond James downgraded the previous rating of Outperform to Market Perform. For the first quarter, Guaranty Bancshares had an EPS of $0.88, compared to year-ago quarter EPS of $0.94. The current stock performance of Guaranty Bancshares shows a 52-week-high of $44.60 and a 52-week-low of $31.65. Moreover, at the end of the last trading period, the closing price was at $36.35.

    According to JP Morgan, the prior rating for Otis Worldwide Corp (NYSE:OTIS) was changed from Overweight to Neutral. Otis Worldwide earned $0.77 in the first quarter, compared to $0.72 in the year-ago quarter. The current stock performance of Otis Worldwide shows a 52-week-high of $92.84 and a 52-week-low of $66.97. Moreover, at the end of the last trading period, the closing price was at $71.26.

    BTIG downgraded the previous rating for T2 Biosystems Inc (NASDAQ:TTOO) from Buy to Neutral. T2 Biosystems earned $0.10 in the first quarter, compared to $0.07 in the year-ago quarter. The current stock performance of T2 Biosystems shows a 52-week-high of $1.23 and a 52-week-low of $0.15. Moreover, at the end of the last trading period, the closing price was at $0.16.

    Berenberg downgraded the previous rating for Rio Tinto PLC (NYSE:RIO) from Hold to Sell. The stock has a 52-week-high of $89.51 and a 52-week-low of $56.02. At the end of the last trading period, Rio Tinto closed at $57.26.

    B of A Securities downgraded the previous rating for Kohl's Corp (NYSE:KSS) from Neutral to Underperform. In the first quarter, Kohl's showed an EPS of $0.11, compared to $1.05 from the year-ago quarter. The stock has a 52-week-high of $64.38 and a 52-week-low of $27.31. At the end of the last trading period, Kohl's closed at $27.37.

    According to B of A Securities, the prior rating for Sealed Air Corp (NYSE:SEE) was changed from Buy to Neutral. Sealed Air earned $1.12 in the first quarter, compared to $0.78 in the year-ago quarter. The stock has a 52-week-high of $70.72 and a 52-week-low of $53.87. At the end of the last trading period, Sealed Air closed at $58.43.

    Baird downgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Outperform to Neutral. Aspen Technology earned $1.38 in the third quarter, compared to $1.05 in the year-ago quarter. The stock has a 52-week-high of $210.59 and a 52-week-low of $122.29. At the end of the last trading period, Aspen Technology closed at $191.34.

    Keybanc downgraded the previous rating for Vtex (NYSE:VTEX) from Overweight to Sector Weight. For the first quarter, Vtex had an EPS of $0.10, compared to year-ago quarter EPS of $0.07. At the moment, the stock has a 52-week-high of $33.36 and a 52-week-low of $2.74. Vtex closed at $3.09 at the end of the last trading period.

    Keybanc downgraded the previous rating for Blend Labs Inc (NYSE:BLND) from Overweight to Sector Weight. The current stock performance of Blend Labs shows a 52-week-high of $21.04 and a 52-week-low of $2.17. Moreover, at the end of the last trading period, the closing price was at $2.70.

    UBS downgraded the previous rating for Kellogg Co (NYSE:K) from Buy to Neutral. Kellogg earned $1.10 in the first quarter, compared to $1.11 in the year-ago quarter. The stock has a 52-week-high of $75.56 and a 52-week-low of $59.54. At the end of the last trading period, Kellogg closed at $72.75.

    According to Citigroup, the prior rating for Consolidated Communications Holdings Inc (NASDAQ:CNSL) was changed from Neutral to Sell. For the first quarter, Consolidated Comms Hldgs had an EPS of $0.02, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $9.70 and a 52-week-low of $4.51. At the end of the last trading period, Consolidated Comms Hldgs closed at $6.98.

    For Bank OZK (NASDAQ:OZK), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. Bank OZK earned $1.02 in the first quarter, compared to $1.11 in the year-ago quarter. The stock has a 52-week-high of $51.39 and a 52-week-low of $34.79. At the end of the last trading period, Bank OZK closed at $37.82.

    For Applied Molecular Transport Inc (NASDAQ:AMTI), Jefferies downgraded the previous rating of Buy to Hold. In the first quarter, Applied Molecular showed an EPS of $1.10, compared to $0.58 from the year-ago quarter. The stock has a 52-week-high of $46.48 and a 52-week-low of $1.97. At the end of the last trading period, Applied Molecular closed at $2.32.

    According to RBC Capital, the prior rating for Boston Beer Co Inc (NYSE:SAM) was changed from Outperform to Sector Perform. Boston Beer Co earned $0.16 in the first quarter, compared to $5.26 in the year-ago quarter. The current stock performance of Boston Beer Co shows a 52-week-high of $990.40 and a 52-week-low of $287.00. Moreover, at the end of the last trading period, the closing price was at $306.23.

    Mizuho downgraded the previous rating for CytomX Therapeutics Inc (NASDAQ:CTMX) from Buy to Neutral. For the first quarter, CytomX Therapeutics had an EPS of $0.37, compared to year-ago quarter EPS of $0.26. The current stock performance of CytomX Therapeutics shows a 52-week-high of $7.53 and a 52-week-low of $1.50. Moreover, at the end of the last trading period, the closing price was at $1.97.

    Piper Sandler downgraded the previous rating for CytomX Therapeutics Inc (NASDAQ:CTMX) from Overweight to Neutral. For the first quarter, CytomX Therapeutics had an EPS of $0.37, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $7.53 and a 52-week-low of $1.50. CytomX Therapeutics closed at $1.97 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    With a Neutral rating, JP Morgan initiated coverage on Rover Group Inc (NASDAQ:ROVR). The price target seems to have been set at $5.00 for Rover Group. For the first quarter, Rover Group had an EPS of $0.08, compared to year-ago quarter EPS of $0.35. The stock has a 52-week-high of $15.59 and a 52-week-low of $3.61. At the end of the last trading period, Rover Group closed at $4.05.

    With an Outperform rating, Cowen & Co. initiated coverage on CTI BioPharma Corp (NASDAQ:CTIC). The price target seems to have been set at $10.00 for CTI BioPharma. CTI BioPharma earned $0.37 in the first quarter, compared to $0.23 in the year-ago quarter. The stock has a 52-week-high of $6.52 and a 52-week-low of $1.43. At the end of the last trading period, CTI BioPharma closed at $6.00.

    With a Buy rating, Roth Capital initiated coverage on Kalera PLC (NASDAQ:KAL). The price target seems to have been set at $6.00 for Kalera. The stock has a 52-week-high of $13.30 and a 52-week-low of $2.53. At the end of the last trading period, Kalera closed at $4.41.

    With a Buy rating, Canaccord Genuity initiated coverage on New Relic Inc (NYSE:NEWR). The price target seems to have been set at $81.00 for New Relic. In the fourth quarter, New Relic showed an EPS of $0.24, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of $129.70 and a 52-week-low of $41.66. At the end of the last trading period, New Relic closed at $52.24.

    With a Buy rating, EF Hutton initiated coverage on Superior Group Of Companies Inc (NASDAQ:SGC). The price target seems to have been set at $29.00 for Superior Gr of Cos. In the first quarter, Superior Gr of Cos showed an EPS of $0.32, compared to $0.66 from the year-ago quarter. The current stock performance of Superior Gr of Cos shows a 52-week-high of $27.25 and a 52-week-low of $14.57. Moreover, at the end of the last trading period, the closing price was at $17.82.

    With a Hold rating, Jefferies initiated coverage on EVgo Inc (NASDAQ:EVGO). The price target seems to have been set at $5.50 for EVgo. The current stock performance of EVgo shows a 52-week-high of $19.59 and a 52-week-low of $5.28. Moreover, at the end of the last trading period, the closing price was at $5.60.

    Needham initiated coverage on Duolingo Inc (NASDAQ:DUOL) with a Buy rating. The price target for Duolingo is set to $115.00. In the first quarter, Duolingo showed an EPS of $0.31, compared to $1.04 from the year-ago quarter. The current stock performance of Duolingo shows a 52-week-high of $205.00 and a 52-week-low of $60.50. Moreover, at the end of the last trading period, the closing price was at $96.95.

    With a Buy rating, Needham initiated coverage on GitLab Inc (NASDAQ:GTLB). The price target seems to have been set at $70.00 for GitLab. In the first quarter, GitLab showed an EPS of $0.18, compared to $0.53 from the year-ago quarter. At the moment, the stock has a 52-week-high of $137.00 and a 52-week-low of $30.74. GitLab closed at $56.01 at the end of the last trading period.

    Chardan Capital initiated coverage on EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) with a Buy rating. The price target for EyePoint Pharmaceuticals is set to $21.00. For the first quarter, EyePoint Pharmaceuticals had an EPS of $0.56, compared to year-ago quarter EPS of $0.50. The current stock performance of EyePoint Pharmaceuticals shows a 52-week-high of $21.50 and a 52-week-low of $7.00. Moreover, at the end of the last trading period, the closing price was at $7.79.

    Mizuho initiated coverage on BioXcel Therapeutics Inc (NASDAQ:BTAI) with a Buy rating. The price target for BioXcel Therapeutics is set to $19.00. In the first quarter, BioXcel Therapeutics showed an EPS of $1.12, compared to $1.08 from the year-ago quarter. The stock has a 52-week-high of $36.49 and a 52-week-low of $8.79. At the end of the last trading period, BioXcel Therapeutics closed at $15.85.

    Mizuho initiated coverage on Intra-Cellular Therapies Inc (NASDAQ:ITCI) with a Buy rating. The price target for Intra-Cellular Therapies is set to $74.00. In the first quarter, Intra-Cellular Therapies showed an EPS of $0.78, compared to $0.65 from the year-ago quarter. The stock has a 52-week-high of $66.00 and a 52-week-low of $28.40. At the end of the last trading period, Intra-Cellular Therapies closed at $56.17.

    With a Buy rating, Mizuho initiated coverage on Athira Pharma Inc (NASDAQ:ATHA). The price target seems to have been set at $6.00 for Athira Pharma. Athira Pharma earned $0.56 in the first quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $16.65 and a 52-week-low of $2.53. At the end of the last trading period, Athira Pharma closed at $3.39.

    Mizuho initiated coverage on Alector Inc (NASDAQ:ALEC) with a Buy rating. The price target for Alector is set to $15.00. In the first quarter, Alector showed an EPS of $0.54, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $40.39 and a 52-week-low of $7.50. Alector closed at $11.56 at the end of the last trading period.

    With a Neutral rating, Mizuho initiated coverage on Cerevel Therapeutics Holdings Inc (NASDAQ:CERE). The price target seems to have been set at $30.00 for Cerevel Therapeutics Hldg. Cerevel Therapeutics Hldg earned $0.46 in the first quarter, compared to $0.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $46.16 and a 52-week-low of $19.59. Cerevel Therapeutics Hldg closed at $30.00 at the end of the last trading period.

    Mizuho initiated coverage on Harmony Biosciences Holdings Inc (NASDAQ:HRMY) with a Buy rating. The price target for Harmony Biosciences is set to $64.00. In the first quarter, Harmony Biosciences showed an EPS of $0.51, compared to $0.38 from the year-ago quarter. At the moment, the stock has a 52-week-high of $55.60 and a 52-week-low of $25.09. Harmony Biosciences closed at $54.92 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ABTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABTX
    $ADVM
    $ALEC
    $AMTI

    CompanyDatePrice TargetRatingAnalyst
    Harmony Biosciences Holdings Inc.
    $HRMY
    2/11/2026$46.00Neutral
    UBS
    Otis Worldwide Corporation
    $OTIS
    1/30/2026$98.00Overweight → Neutral
    Analyst
    Rio Tinto Plc
    $RIO
    1/28/2026Overweight → Equal-Weight
    Morgan Stanley
    Texas Capital Bancshares Inc.
    $TCBI
    1/27/2026$93.00 → $102.00Market Perform
    Hovde Group
    Rio Tinto Plc
    $RIO
    1/23/2026Hold → Buy
    Erste Group
    Pathward Financial Inc.
    $CASH
    1/23/2026$100.00Mkt Perform → Outperform
    Keefe Bruyette
    Southern Copper Corporation
    $SCCO
    1/23/2026$117.50Neutral → Underweight
    Analyst
    SmartFinancial Inc.
    $SMBK
    1/22/2026$48.00Market Perform → Outperform
    Hovde Group
    More analyst ratings

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHAIRMAN OF THE BOARD Welborn Wesley Miller bought $36,014 worth of shares (835 units at $43.13), increasing direct ownership by 0.87% to 96,468 units (SEC Form 4)

    4 - SMARTFINANCIAL INC. (0001038773) (Issuer)

    2/10/26 5:00:05 PM ET
    $SMBK
    Major Banks
    Finance

    Director Stallings Robert W bought $360,579 worth of Depositary Shares for Series B Preferred Stock (16,885 units at $21.35) (SEC Form 4)

    4 - TEXAS CAPITAL BANCSHARES INC/TX (0001077428) (Issuer)

    2/6/26 4:05:24 PM ET
    $TCBI
    Major Banks
    Finance

    Director Stallings Robert W bought $86,760 worth of Depositary Shares for Series B Preferred Stock (4,115 units at $21.08) (SEC Form 4)

    4 - TEXAS CAPITAL BANCSHARES INC/TX (0001077428) (Issuer)

    2/4/26 4:11:21 PM ET
    $TCBI
    Major Banks
    Finance

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    SEC Filings

    View All

    SEC Form DEFM14A filed by Heritage Commerce Corp

    DEFM14A - HERITAGE COMMERCE CORP (0001053352) (Filer)

    2/12/26 4:46:36 PM ET
    $HTBK
    Major Banks
    Finance

    SEC Form 144 filed by Pinnacle Financial Partners Inc.

    144 - Pinnacle Financial Partners, Inc. (0002082866) (Subject)

    2/12/26 2:28:40 PM ET
    $PNFP
    Major Banks
    Finance

    SEC Form 8-K filed by Canadian Pacific Kansas City Limited

    8-K - CANADIAN PACIFIC KANSAS CITY LTD/CN (0000016875) (Filer)

    2/12/26 12:27:55 PM ET
    $CP
    Railroads
    Industrials

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Marketing Officer Guindo Chirfi sold $1,214,562 worth of shares (10,000 units at $121.46), decreasing direct ownership by 14% to 60,615 units (SEC Form 4)

    4 - Merck & Co., Inc. (0000310158) (Issuer)

    2/12/26 4:02:53 PM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Information Officer Fluhler Stephan sold $174,596 worth of shares (4,161 units at $41.96), decreasing direct ownership by 16% to 22,000 units (SEC Form 4)

    4 - FIRST MERCHANTS CORP (0000712534) (Issuer)

    2/12/26 3:00:09 PM ET
    $FRME
    Major Banks
    Finance

    Amendment: SEC Form 4 filed by Chief Info./Digital Off., Bank Derraik Renato

    4/A - Live Oak Bancshares, Inc. (0001462120) (Issuer)

    2/11/26 8:34:04 PM ET
    $LOB
    Major Banks
    Finance

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EPR Properties Declares Monthly Dividend for Common Shareholders

    EPR Properties (NYSE:EPR) today announced that its Board of Trustees has declared its monthly cash dividend to common shareholders. The dividend of $0.295 per common share is payable March 16, 2026 to shareholders of record on February 27, 2026. This dividend represents an annualized dividend of $3.54 per common share. About EPR Properties EPR Properties (NYSE:EPR) is the leading diversified experiential net lease real estate investment trust (REIT), specializing in select enduring experiential properties in the real estate industry. We focus on real estate venues which create value by facilitating out of home leisure and recreation experiences where consumers choose to spend their disc

    2/12/26 4:15:00 PM ET
    $EPR
    Real Estate Investment Trusts
    Real Estate

    1st Security Bank CEO Matthew Mullet joins the Federal Reserve Bank of San Francisco's Seattle Branch Board of Directors

    MOUNTLAKE TERRACE, Wash., Feb. 12, 2026 (GLOBE NEWSWIRE) -- FS Bancorp, Inc. (NASDAQ:FSBW), the holding company for 1st Security Bank of Washington ("1st Security" or "Bank") announces the appointment of Matthew Mullet, Bank Chief Executive Officer, to the Seattle Branch Board of Directors for the Federal Reserve Bank of San Francisco (SF Fed). 1st Security Bank is pleased to announce the appointment of Matt Mullet, CEO and President of the Bank, to a directorship with the SF Fed's Seattle Branch Board. The SF Fed is one of 12 Reserve Banks in the Federal Reserve System that work to advance the nation's monetary, financial, and payment systems to build a stronger economy for all Americ

    2/12/26 3:23:46 PM ET
    $FSBW
    Banks
    Finance

    Blend Expands Deep Verification Capabilities to Drive Speed and Improve Borrower Experience for Lenders

    Best-in-class Verification of Income and Verification of Assets help lenders streamline home lending originations and remove friction for borrowers. Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform for banks, credit unions, and mortgage lenders, today announced the expansion of its Verification of Income capability, powered by a partnership with Truework. The company also announced the addition of supplemental asset reports to verify borrower employment during the pre-close verification process, expanding the benefits of its Verification of Assets solution for mortgage lenders. Verification of Income and Employment Blend enhanced its Verification of Income and Empl

    2/12/26 1:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Harmony Biosciences with a new price target

    UBS resumed coverage of Harmony Biosciences with a rating of Neutral and set a new price target of $46.00

    2/11/26 7:39:03 AM ET
    $HRMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Otis Worldwide downgraded by Analyst with a new price target

    Analyst downgraded Otis Worldwide from Overweight to Neutral and set a new price target of $98.00

    1/30/26 1:10:46 PM ET
    $OTIS
    Consumer Electronics/Appliances
    Technology

    Rio Tinto downgraded by Morgan Stanley

    Morgan Stanley downgraded Rio Tinto from Overweight to Equal-Weight

    1/28/26 7:14:20 AM ET
    $RIO
    Metal Mining
    Basic Materials

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for IGALMI issued to BIOXCEL THERAPEUTICS, INC.

    Submission status for BIOXCEL THERAPEUTICS, INC.'s drug IGALMI (ORIG-1) with active ingredient DEXMEDETOMIDINE has changed to 'Approval' on 04/05/2022. Application Category: NDA, Application Number: 215390, Application Classification: Type 3 - New Dosage Form

    4/6/22 2:18:32 PM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Leadership Updates

    Live Leadership Updates

    View All

    1st Security Bank CEO Matthew Mullet joins the Federal Reserve Bank of San Francisco's Seattle Branch Board of Directors

    MOUNTLAKE TERRACE, Wash., Feb. 12, 2026 (GLOBE NEWSWIRE) -- FS Bancorp, Inc. (NASDAQ:FSBW), the holding company for 1st Security Bank of Washington ("1st Security" or "Bank") announces the appointment of Matthew Mullet, Bank Chief Executive Officer, to the Seattle Branch Board of Directors for the Federal Reserve Bank of San Francisco (SF Fed). 1st Security Bank is pleased to announce the appointment of Matt Mullet, CEO and President of the Bank, to a directorship with the SF Fed's Seattle Branch Board. The SF Fed is one of 12 Reserve Banks in the Federal Reserve System that work to advance the nation's monetary, financial, and payment systems to build a stronger economy for all Americ

    2/12/26 3:23:46 PM ET
    $FSBW
    Banks
    Finance

    Core Natural Resources Reports Fourth Quarter 2025 Results

    Resumes longwall mining at Leer South, enters 2026 operating at targeted production ratesCompletes transition to new seam at West Elk, enters 2026 operating at targeted production ratesGenerates net cash provided by operating activities of $107.3 million and free cash flow1 of $27.0 millionSignificantly increases contracted position in all segments, at prices projected to drive advantageous margins Returns $26.8 million to stockholders, bringing the total returned to stockholders in 2025 to $245.1 million CANONSBURG, Pa., Feb. 12, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE:CNR) ("Core" or the "company") reported a net loss of $79.0 million, or ($1.54) per diluted share, i

    2/12/26 6:55:00 AM ET
    $CNR
    Coal Mining
    Energy

    Regions Bank Names Kafi Slaughter as Private Wealth Leader Serving Key Texas Markets

    Slaughter's industry experience, passion for superior service, and deep community engagement will further differentiate how Regions serves clients in Houston, Austin and beyond. Regions Bank on Wednesday announced Kafi Slaughter has joined the bank to serve as area wealth leader for Private Wealth Management, guiding clients through comprehensive planning, customized investment strategies, fiduciary services, personalized financial guidance, and banking and lending solutions across Houston, Austin, San Antonio, and other rapidly growing markets in the southern half of the Lone Star State. This press release features multimedia. View the full release here: https://www.businesswire.com/new

    2/11/26 9:00:00 AM ET
    $RF
    Major Banks
    Finance

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Tenaris S.A.

    SC 13D/A - TENARIS SA (0001190723) (Subject)

    12/9/24 4:53:51 PM ET
    $TS
    Steel/Iron Ore
    Industrials

    SEC Form SC 13G filed by Alector Inc.

    SC 13G - Alector, Inc. (0001653087) (Subject)

    12/6/24 5:30:28 PM ET
    $ALEC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by PNC Financial Services Group Inc.

    SC 13G/A - PNC FINANCIAL SERVICES GROUP, INC. (0000713676) (Filed by)

    11/14/24 8:22:26 PM ET
    $PNC
    Major Banks
    Finance

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Financials

    Live finance-specific insights

    View All

    EPR Properties Declares Monthly Dividend for Common Shareholders

    EPR Properties (NYSE:EPR) today announced that its Board of Trustees has declared its monthly cash dividend to common shareholders. The dividend of $0.295 per common share is payable March 16, 2026 to shareholders of record on February 27, 2026. This dividend represents an annualized dividend of $3.54 per common share. About EPR Properties EPR Properties (NYSE:EPR) is the leading diversified experiential net lease real estate investment trust (REIT), specializing in select enduring experiential properties in the real estate industry. We focus on real estate venues which create value by facilitating out of home leisure and recreation experiences where consumers choose to spend their disc

    2/12/26 4:15:00 PM ET
    $EPR
    Real Estate Investment Trusts
    Real Estate

    VTEX to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 26th, 2026

    VTEX (NYSE:VTEX), the backbone for connected commerce, will release the financial results for its fourth fiscal quarter and fiscal year ended December 31st, 2025, via conference call and audio webcast, on February 26th, 2026, at 4:30 pm Eastern Time. The conference call may be accessed by dialing +1-800-715-9871 (Conference ID –3544576–) and requesting inclusion in the call for VTEX. The live conference call can be accessed via audio webcast at the investor relations section of the Company's website at https://www.investors.vtex.com/. An archived webcast replay will be available following the call's conclusion. About VTEX VTEX (NYSE:VTEX) is the commerce suite of choice for bold CIOs

    2/11/26 4:01:00 PM ET
    $VTEX
    Computer Software: Prepackaged Software
    Technology

    First Merchants Corporation Announces Cash Dividend

    MUNCIE, Ind, Feb. 10, 2026 (GLOBE NEWSWIRE) -- First Merchants Corporation declared a cash dividend on February 9, 2026 of $0.36 per common share. The dividend is payable on March 20, 2026 to common shareholders of record as of March 6, 2026. About First Merchants Corporation: First Merchants Corporation is a financial holding company headquartered in Muncie, Indiana. The Corporation has one full-service bank charter, First Merchants Bank. The Bank also operates as First Merchants Private Wealth Advisors (as a division of First Merchants Bank). First Merchants Corporation's common stock is traded on the NASDAQ Global Select Market System under the symbol FRME. Quotations are carried in

    2/10/26 11:25:00 AM ET
    $FRME
    Major Banks
    Finance

    $ABTX
    $ADVM
    $ALEC
    $AMTI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Athira Pharma Inc. on Jun 25

    Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

    6/26/24 3:07:15 PM ET
    $ATHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care